Medicare Enrolled
Dr. Mahmood Kazmi
Optician · Bronx, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kazmi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kazmi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kazmi
Dr. Mahmood Kazmi is an optician specialist in Bronx, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kazmi performed 4,679 Medicare services across 3,474 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kazmi received a total of $183,857 from 66 pharmaceutical and/or device companies across 1375 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kazmi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 17% volume in NY
$183,857 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,679
Medicare services
Top 17% in NY for optician
3,474
Unique beneficiaries
$109
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~234 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
1,335 | $163 | $328 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
965 | $97 | $247 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
420 | $68 | $249 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
364 | $79 | $200 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
275 | $112 | $299 |
| Psychotherapy and evaluation, 30 minutes A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes. |
225 | $61 | $250 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
167 | $71 | $250 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
139 | $122 | $259 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
109 | $43 | $200 |
| Health risk assessment administration and interpretation This procedure involves administering a health risk assessment to a patient and interpreting the results. |
104 | $2 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
77 | $151 | $348 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
73 | $58 | $200 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
67 | $158 | $350 |
| Psychiatric diagnostic evaluation with medical services A psychiatric assessment that includes medical services to evaluate mental health conditions. |
61 | $170 | $466 |
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
54 | $137 | $383 |
| Annual depression screening | 52 | $22 | $75 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
37 | $120 | $450 |
| Chronic care management services Comprehensive assessment and care planning for patients requiring ongoing chronic care management. |
37 | $57 | $200 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
31 | $72 | $125 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
28 | $91 | $200 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $52 | $75 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
21 | $99 | $195 |
| New patient office visit, complex (60-74 min) | 15 | $205 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$183,857
Total received (2018-2024)
Avg $26,265/year across 7 years
Top 3% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
1,375
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$170,227 (92.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,630 (7.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$13,560
2023
$37,666
2022
$33,637
2021
$48,328
2020
$30,348
2019
$17,363
2018
$2,955
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$11,648
PFIZER INC.
$460
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$428
Otsuka America Pharmaceutical, Inc.
$399
Novartis Pharmaceuticals Corporation
$146
EMD Serono, Inc.
$101
Alexion Pharmaceuticals, Inc.
$59
Amneal Pharmaceuticals LLC
$40
Neuronetics, Inc.
$35
Eisai Inc.
$32
Neurelis, Inc.
$27
Alkermes, Inc.
$26
Lundbeck LLC
$24
Teva Pharmaceuticals USA, Inc.
$22
Biogen, Inc.
$21
ARGENX US, INC.
$19
Medtronic, Inc.
$17
Amgen Inc.
$16
Sumitomo Pharma America, Inc.
$15
Aucta Pharmaceuticals, Inc.
$13
Lilly USA, LLC
$13
Top 3 companies account for 92.4% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$72,555
Allergan, Inc.
$32,978
AbbVie Inc.
$30,558
Allergan Inc.
$15,384
Biohaven Pharmaceuticals, Inc.
$11,735
Biohaven Pharmaceutical Holding Company Ltd.
$7,128
Amneal Pharmaceuticals LLC
$1,338
Teva Pharmaceuticals USA, Inc.
$1,053
Novartis Pharmaceuticals Corporation
$937
PFIZER INC.
$923
EMD Serono, Inc.
$922
ITI, Inc.
$686
Otsuka America Pharmaceutical, Inc.
$622
Avanir Pharmaceuticals, Inc.
$610
Lundbeck LLC
$577
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$428
NOVARTIS PHARMACEUTICALS CORPORATION
$376
Alexion Pharmaceuticals, Inc.
$367
Adamas Pharmaceuticals, Inc.
$359
Biogen, Inc.
$322
Amgen Inc.
$316
ACADIA Pharmaceuticals Inc
$288
GENZYME CORPORATION
$257
Acorda Therapeutics, Inc
$208
E.R. Squibb & Sons, L.L.C.
$200
Medtronic, Inc.
$188
Janssen Pharmaceuticals, Inc
$188
BOSTON SCIENTIFIC CORPORATION
$173
Medtronic USA, Inc.
$141
Kyowa Kirin, Inc.
$129
Lilly USA, LLC
$128
Shire North American Group Inc
$115
Eisai Inc.
$108
UCB, Inc.
$108
Grifols USA, LLC
$105
Impax Laboratories, Inc.
$103
Abbott Laboratories
$99
Neurocrine Biosciences, Inc.
$88
Axsome Therapeutics, Inc.
$84
Currax Pharmaceuticals LLC
$69
SK Life Science, Inc.
$69
Mallinckrodt Enterprises LLC
$63
CSL Behring
$63
ARGENX US, INC.
$61
Baxter Healthcare
$55
Sumitomo Pharma America, Inc.
$54
Almatica Pharma LLC
$52
Neurelis, Inc.
$46
Takeda Pharmaceuticals U.S.A., Inc.
$45
Celgene Corporation
$36
Neuronetics, Inc.
$35
Horizon Therapeutics plc
$35
Vertical Pharmaceuticals, LLC
$32
GE HealthCare
$30
Mallinckrodt LLC
$27
Alkermes, Inc.
$26
Alnylam Pharmaceuticals Inc.
$25
US WorldMeds, LLC
$22
Genentech USA, Inc.
$21
Merck Sharp & Dohme LLC
$20
MITSUBISHI TANABE PHARMA AMERICA, INC.
$19
Supernus Pharmaceuticals, Inc.
$15
Kowa Pharmaceuticals America, Inc.
$15
Bausch Health US, LLC
$14
Aucta Pharmaceuticals, Inc.
$13
Vanda Pharmaceuticals Inc.
$12
Top 3 companies account for 74.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADASUVE · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · Auvelity · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRINTELLIX · Briviact · CAPLYTA · COMIRNATY · CONTRAVE · DUOPA · EMGALITY · Fycompa · GOCOVRI · GRALISE · Gamunex-C · HETLIOZ · Hillrom - Carnation Ambulatory Monitor · Hizentra · INBRIJA · INFINITY · INGREZZA · INTELLIS ADAPTIVESTIM · Infinity DBS Pulse Generators · KESIMPTA · LEMTRADA · LINZESS · LYBALVI · LYRICA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYDAYIS · Mavenclad · Motpoly XR · NAMZARIC · NEUROSTAR TMS THERAPY SYSTEM · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · OSMOLEX ER · PANZYGA · PERCEPT PC BRAINSENSE · QULIPTA · RADICAVA · REXULTI · RYTARY · Rebif · SEGLENTIS · SKYCLARYS · SOLIRIS · SPECTRA WAVEWRITER · SPINRAZA · Soliris · TECFIDERA · TRINTELLIX · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIIBRYD · VRAYLAR · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vimpat · Xadago · ZEPOSIA · ZOMIG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for optician in NY.
Geographic Context
Opticians within 10 mi
16,489
Per 100K population
1161.8
County median income
$49,036
Nearest hospital
MONTEFIORE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kazmi is a clinical cardiology specialist, with above-average Medicare volume (top 17% in NY), with speaking/promotional industry engagement in the top 3% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kazmi experienced with initial nursing facility care, high complexity?
Based on Medicare claims data, Dr. Kazmi performed 1,335 initial nursing facility care, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kazmi receive payments from pharmaceutical companies?
Yes. Dr. Kazmi received a total of $183,857 from 66 companies across 1,375 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kazmi's costs compare to other opticians in Bronx?
Dr. Kazmi's average Medicare payment per service is $109. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kazmi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Bronx
Browse opticians in Bronx ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NY
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NY
Which NY opticians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology